Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.


The Sandra and Edward Meyer Cancer Center marks a critical step in the transformation and acceleration of personalized translational medicine, research and clinical care for cancer patients.


We are a collaborative, multidisciplinary research enterprise located at Weill Cornell Medicine, one of the top-ranked clinical and medical research centers in the country, in affiliation with NewYork-Presbyterian Hospital, the best hospital in New York according to U.S. News & World Report. The Meyer Cancer Center engages more than 250 basic scientists, pathologists, bioinformaticians, surgeons, oncologists, radiologists and other clinicians, who collaborate with colleagues at Cornell University’s Ithaca campus and other institutions to take fundamental discoveries from bench to bedside, and back again. 

•  Our leaders •  Our researchers  •  Our physicians  •  Our supporters


Our mission is to ensure that patients have access to emerging new therapies in a supportive and caring environment, while training future researchers and recruiting leaders in cancer research and clinical care.


We provide personalized, compassionate care that is state-of-the-art, not out-of-the-box. We take the time to get to know our patients, and partner with them to devise the best available evaluation and treatment program, whether that be through standard care or participation in some of our innovative clinical trials. We also provide access to a full range of resources needed for comprehensive cancer care. This includes nutrition, psychosocial support, complementary medicine, rehabilitation, pain management, cardiac and pulmonary care, and an array of specialists across all medical specialties.


By delving deeply into research that explores basic biological processes, genetic abnormalities and pathological states, we are making unparalleled progress in our understanding of the molecular events that cause cancer and in our ability to translate this knowledge into new approaches for prevention, treatment and cure. We tackle cancer through two basic science and two translational/clinical research programs. The creation of a centralized biobank in partnership with the Englander Institute for Precision Medicine is creating further opportunities for lab and clinical advances.


Founded in 1898, and affiliated with what is now NewYork-Presbyterian Hospital since 1927, Weill Cornell Medicine is among the top-ranked clinical and medical research centers in the country. In addition to offering medical degrees, Weill Cornell Medicine also has Ph.D. programs in biomedical research and education at the Weill Cornell Graduate School of Medical Sciences, and a joint MD-Ph.D. program with the neighboring Sloan-Kettering Institute and The Rockefeller University. Graduate students, medical students, postdocs and clinical fellows are valued members of our research labs.

Visiting Us

Meyer Cancer Center at Weill Cornell is best cancer care in NYC

1300 York Avenue, New York, NY, 10065     Administration: (646) 962-6132     Clinical Services: (646) 962-2800

From Our Director

Innovation from Weill Cornell Medicine scientists + the best medical care from NewYork-Presbyterian doctors puts Meyer Cancer Center first in NYC cancer care
“The Meyer Cancer Center champions a dramatic shift in the paradigm for translational biomedical research and clinical care, by engaging basic scientists, pathologists, bioinformaticians, surgeons, radiation oncologists and radiologists, who collaborate daily to move their discoveries from the bench to clinical trials and ultimately into therapies for patients. Interactions with patients also inform our research and drive further clinical innovation. This interdisciplinary model is the future of biomedicine and will transform the way medical research is conducted. Welcome to the Meyer Cancer Center and the future of science-led, patient-centered cancer therapy.”

Lewis C. Cantley, Ph.D.
Meyer Director 
Professor of Cancer Biology in Medicine